Pharma Pulse 5/16/24: Senators Propose $32 Billion in Annual AI Spending but Defer Regulation, Talkspace Expands Tele-Mental Health to Medicare & more
The latest news for pharma industry insiders.
In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora discusses ways that cell and gene therapy developers can follow examples from the commercialization and distribution of orphan drugs.
Talkspace Expands Tele-Mental Health to Medicare
Talkspace has begun providing its online behavioral health program to traditional Medicare beneficiaries in 11 states, reaching about 13 members. By the end of this year, Talkspace plans to be available to all 33 million traditional Medicare members, along with several Medicare Advantage plans, across all 50 states.
Senators Propose $32 Billion in Annual A.I. Spending but Defer Regulation
Their plan is the culmination of a yearlong listening tour on the dangers of the new technology.
Walgreens Brand Naloxone Available Online and In Stores This Month
Walgreens announced it is expanding access to an over the counter, life-saving medication with the launch of Walgreens Brand Naloxone HCI Nasal Spray. The product—which retails for $34.99, a lower price than the comparable national brand product at Walgreens stores, can reverse an overdose from opioids. The product is currently available online and will be chainwide in all stores by the end of the month, where it can be found in the pain aisle, providing a critical point of access for the nearly 10 million customers and patients the company serves every day in local communities throughout the U.S.
#RFID supports a more efficient and accurate medication-use process that can enhance #patientsafety, help prevent drug diversion, and give clinicians more time for patient care.https://ow.ly/Q5sY50RAizt Pharmaceutical Commerce Magazine Fresenius Kabi #GS1Standards
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
